Cite
MLA Citation
Giuseppe Procopio et al.. “Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.” Future oncology, vol. 10, 2014, pp. 1741–1750. http://access.bl.uk/ark:/81055/vdc_100144466906.0x00000f